LRRK2 expression in colonic biopsy specimens from patients with CD. A, Paired biopsy specimens from intestinal tissues of patients with IBD (inactive disease state) were collected: one specimen from an inflamed area and one from a control noninflamed area for each patient. Total mRNA was extracted and used for qRT-PCR. The amount of LRRK2 mRNA relative to GAPDH mRNA of each inflamed biopsy specimen was normalized to the quantity measured in the corresponding noninflamed biopsy specimen obtained from the same patient. Statistical analyses were performed using Student t test (*p < 0.05). B and C, Frozen sections (7 μm) were prepared from colonic biopsy specimens obtained from patients with IBD. Tissues were immunolabeled with rabbit anti-LRRK2 (clone 267) and rat anti–troma-1 Abs to detect intestinal epithelial cells. The image gallery in B was performed with anti-LRRK2 Abs preincubated or not with its corresponding blocking peptide. C, Mouse monoclonal anti-CD3, anti-CD19, anti-myeloperoxidase, anti-mannose receptor (MNR), and anti-CD103 Abs were also used to detect T-lymphocytes, B-lymphocytes, neutrophils, macrophages, and dendritic cells, respectively. After immunostaining using secondary FITC-anti–mouse, Cy3-anti–rabbit and Cy5-anti–rat species-specific Abs, fluorescence was detected by confocal microscopy. The image gallery displays single confocal sections (original magnification ×60). The bottom panel arrows indicate the cells containing signals from both LRRK2 and FITC-MNR, CD103, CD20, and CD3 cell specific markers, respectively.